DocDollars

Puma Biotechnology, Inc.

CA · United States · Reporting entity ID 100000191750

Total reported 2019–2025
$40.0M
#197 of 2,960 reporting companies — 0% of all reported industry payments
$6.14M in general payments across 34,706 records, plus $33.9M in research funding across 2,195 records.

How it breaks down

General payments $6,140,537
Research funding $33,892,085

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Puma Biotechnology, Inc. reported $40.0M to US doctors and teaching hospitals from 2019 to 2025, ranking #197 of 2,960 reporting companies. 85% of that was research funding and 15% general payments such as consulting, speaking, food and travel. 34,706 general payment records and 2,195 research records were filed.

Common questions about Puma Biotechnology, Inc.

How much has Puma Biotechnology, Inc. paid US doctors?

Puma Biotechnology, Inc. reported $40,032,622 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $6,140,537 in general payments, $33,892,085 in research funding.

How does Puma Biotechnology, Inc. rank among drug and device companies?

It ranks #197 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Puma Biotechnology, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.